Chronic graft versus host disease – Life with Disease

Go back

Chronic graft versus host disease is a serious complication that can develop after receiving donor stem cells, when those new cells begin to attack the body they were meant to heal. Understanding this condition, its impact, and available treatments can help patients and families navigate the challenging journey ahead.

Prognosis

The outlook for chronic graft versus host disease varies widely from person to person, depending on which organs are affected, how severe the symptoms are, and how well the body responds to treatment. This uncertainty can be difficult to accept, especially after surviving the intensive process of stem cell transplantation. Most cases of chronic graft versus host disease are mild to moderate in severity, which offers hope for many patients. However, about 10 to 15 percent of patients develop more severe symptoms that require longer and more intensive treatment.[3]

The good news is that active chronic graft versus host disease most often goes away within five to eight years, though it may not always resolve without leaving some permanent changes to the affected organs.[5] The majority of patients with chronic graft versus host disease typically require treatment for three to five years. However, approximately 15 percent of patients need treatment for a longer period, and in rare cases, some individuals may require lifelong use of drugs that suppress the immune system.[3]

The length of time someone experiences chronic graft versus host disease can vary considerably. Many people see a gradual improvement over several months. The average duration ranges from one to three years, though some individuals live with the condition for longer periods.[14] Survival and quality of life depend heavily on early detection, proper treatment, and comprehensive supportive care throughout the recovery journey.

⚠️ Important
Because chronic graft versus host disease usually develops more than 100 days after transplant, when weekly visits with the transplant team have ended, it becomes crucial to examine your body weekly for signs of the disease. Carefully inspect your mouth, eyes, skin, joints, and genitals for any changes, and report anything unusual to your doctor immediately, even if the changes seem subtle.[3]

Natural Progression

Chronic graft versus host disease develops when the donated stem cells, now established in the recipient’s body, begin to recognize the recipient’s organs and tissues as foreign and launch an attack against them. Unlike acute graft versus host disease (which typically appears within the first 100 days after transplant), chronic graft versus host disease tends to develop more slowly. In most cases, symptoms appear sometime within the first year after transplant, though the condition can arise at any time after receiving donor cells.[4]

The disease involves a complex, multistep process that begins with early inflammation and tissue injury. This is followed by chronic inflammation, abnormal tissue repair, and the development of fibrosis (tissue thickening and scarring). These symptoms resemble those caused by certain autoimmune diseases, where the body’s immune system mistakenly attacks healthy organs.[8]

If left untreated, chronic graft versus host disease can progressively worsen, affecting more organs and causing increasingly severe symptoms. The disease most commonly affects the skin, liver, gastrointestinal tract, and lungs, but it can affect any part of the body.[6] Without intervention, the inflammation and scarring can lead to permanent damage to affected organs, significantly impacting quality of life and potentially becoming life-threatening.

The natural course of the disease varies greatly among individuals. Some patients experience symptoms that remain stable for extended periods, while others face rapidly progressing complications. Many people who develop chronic graft versus host disease previously had acute graft versus host disease, suggesting a continuum of immune system problems following transplant.[3]

Possible Complications

Chronic graft versus host disease can lead to numerous complications that extend beyond the primary symptoms. These complications often arise from the persistent inflammation, scarring, and immune system dysfunction that characterize the disease. Understanding these potential complications helps patients and caregivers recognize warning signs and seek timely medical attention.

When the disease affects the skin, complications can include permanent skin tightening and thickening, which may restrict movement and cause discomfort. Hair loss on the head and body may occur, and nail changes can develop, affecting both appearance and function.[6] These visible changes can significantly impact self-esteem and how patients perceive themselves.

Eye involvement can lead to serious complications including chronic dry eyes, vision changes, and a persistent gritty feeling in the eyes. Without proper treatment, these symptoms can cause lasting damage to the corneas and affect daily activities like reading or driving.[1]

In the mouth, chronic graft versus host disease can cause painful sores, severe dry mouth, gum disease, and difficulty opening the mouth fully. This can make eating, speaking, and maintaining proper dental hygiene extremely challenging. Sensitivity to spicy foods may develop, further limiting dietary choices.[4]

Lung complications represent some of the most serious consequences of chronic graft versus host disease. The disease can cause scarring and inflammation in the airways, leading to persistent cough, shortness of breath, and reduced lung function. These respiratory problems can severely limit physical activity and increase the risk of lung infections.[1]

Gastrointestinal complications include ongoing nausea, vomiting, and diarrhea, which can lead to malnutrition, weight loss, and dehydration. The liver may develop elevated enzyme levels and jaundice (yellowing of the skin and eyes), indicating liver dysfunction that requires careful monitoring.[6]

Joint and muscle complications can cause significant disability. Patients may experience muscle weakness, cramping, and pain, along with decreased range of motion in joints. This can make performing everyday tasks difficult and may require physical therapy to maintain mobility and function.[1]

Genital involvement can cause vaginal dryness, itchiness, or pain with intercourse in women, and similar symptoms affecting the penis or scrotum in men. These complications can significantly impact intimate relationships and quality of life, yet patients may feel uncomfortable discussing them with healthcare providers.[6]

Because chronic graft versus host disease affects the immune system, patients face an increased risk of infections. The immunosuppressive medications used to treat the condition further compromise the body’s ability to fight off bacteria, viruses, and fungi, making infection prevention a critical aspect of care.[7]

Impact on Daily Life

Living with chronic graft versus host disease affects virtually every aspect of daily life, from physical activities to emotional well-being, social relationships, and work responsibilities. The disease can feel like a full-time job, requiring constant attention to symptoms, medications, medical appointments, and self-care strategies.[13]

Physical limitations can be profound. Fatigue is a common and often overwhelming symptom that makes even simple tasks feel exhausting. Patients may struggle with basic activities like getting dressed, preparing meals, or walking short distances. The unpredictable nature of symptoms means people must build flexibility into their plans, never quite knowing how they will feel from one day to the next.[10]

When chronic graft versus host disease affects the joints and muscles, the resulting pain and decreased range of motion can limit mobility and independence. Gentle exercises to improve range of movement may help, but finding the energy and motivation to perform them regularly can be challenging when dealing with persistent discomfort and fatigue.[14]

The emotional toll of chronic graft versus host disease can be just as difficult as the physical symptoms. After surviving the intense process of stem cell transplantation, developing this complication feels like a cruel setback. Many patients experience feelings of sadness, anxiety, confusion, and frustration. Physical changes, fatigue, sleep problems, and some of the medications used to treat chronic graft versus host disease can cause depression, mood swings, and exaggerated feelings of anger or excitement.[10]

Living with chronic graft versus host disease sometimes feels like an emotional roller coaster, with ups and downs and unexpected twists and turns. The uncertainty about whether things will improve or worsen, and not knowing how long the condition will last, creates ongoing stress. This is why many patients and caregivers describe the experience as a marathon rather than a sprint.[10]

Social relationships often suffer when chronic graft versus host disease disrupts normal life. Patients may need to limit social activities due to infection risk, fatigue, or uncomfortable symptoms. Visible changes in appearance, such as skin rashes, hair loss, or weight changes, can affect self-confidence and make social interactions feel awkward. Some people withdraw from friends and family, either because they lack energy for socializing or because they feel others cannot understand what they are going through.[11]

Work life presents its own set of challenges. Many patients cannot return to their previous employment, at least temporarily, due to physical limitations, frequent medical appointments, and the need to avoid infection. This loss of work identity, combined with financial stress, can be emotionally devastating. For those who do return to work, managing symptoms while maintaining job responsibilities requires significant effort and often special accommodations.[11]

Intimate relationships and sexuality can be affected by both physical symptoms and emotional stress. Genital involvement causing pain or discomfort during intercourse, combined with fatigue and body image concerns, can strain partnerships. Open communication with partners about feelings, worries, and needs becomes essential for maintaining relationship health.[14]

Despite these challenges, many patients find ways to adapt and cope. Learning to manage chronic graft versus host disease without being defined by it becomes the goal. Taking each day as it comes, focusing on what one can do rather than what one cannot, and noticing small things that bring joy and pleasure can help maintain a sense of normalcy and hope. Engaging in non-medical activities that remind patients of who they are as individuals, beyond their illness, supports psychological well-being.[10]

⚠️ Important
If you are experiencing symptoms of depression, anxiety, confusion, or mood swings while living with chronic graft versus host disease, it is important to let your doctor know. Medications are sometimes offered to help stabilize mood swings and reduce anxiety, and short-term use of these drugs does not mean you will become dependent on them long-term.[10]

Support for Family

Family members and caregivers play a crucial role in helping patients navigate the challenges of chronic graft versus host disease, including exploring clinical trial options. Understanding what clinical trials are, how they work, and how to find appropriate studies can empower families to support their loved ones in making informed decisions about participating in research.

Clinical trials are research studies that test new treatments or approaches to managing chronic graft versus host disease. These studies are essential for developing better therapies, as the medical community continues to search for more effective ways to prevent and treat this condition. While systemic corticosteroids remain the first line of treatment for chronic graft versus host disease, clinical trials offer access to novel agents and approaches that may benefit patients whose symptoms do not respond adequately to standard treatments.[7]

Recently, several new treatments for chronic graft versus host disease have been approved based on results from clinical trials. These include medications such as ibrutinib, ruxolitinib, and belumosudil, which work through different mechanisms to control the overactive immune response. The development and approval of these drugs demonstrate how clinical trials directly translate into better care options for patients.[8]

Families should know that patients may want to consider joining a clinical trial, especially if chronic graft versus host disease has returned or has become worse despite treatment. Clinical trials are taking place across the country, offering various approaches to managing both acute and chronic forms of graft versus host disease.[5]

When supporting a loved one in finding and preparing for clinical trial participation, family members can help in several practical ways. First, they can assist with research by using online resources to identify trials that match the patient’s specific situation. Transplant centers often have information about available studies, and healthcare providers can offer recommendations about appropriate trials.

Preparing for trial participation involves understanding the study requirements, potential benefits and risks, time commitments, and any travel that may be necessary. Family members can help by attending appointments with the patient, taking notes, asking questions, and helping to organize information. Having a support person present during discussions about clinical trials ensures that important details are not missed and provides emotional support during decision-making.

Transportation to and from trial appointments often falls to family members, especially when patients feel too fatigued or unwell to drive themselves. Keeping track of medication schedules, symptom diaries, and appointment calendars can be overwhelming for patients dealing with chronic graft versus host disease, and family assistance with these organizational tasks can reduce stress.

Emotional support is perhaps the most valuable contribution families can make. Living with chronic graft versus host disease can be an emotionally difficult experience for both patients and their families. After transplant, everyone wants to resume a normal life, but chronic graft versus host disease can make that difficult for a time.[10]

It is important for family members not to ignore or downplay their own feelings. Finding outlets to express and process emotions can decrease stress, facilitate problem-solving, and help everyone move forward in a healthy manner. Many transplant centers have social workers, psychologists, or pastoral counselors with experience working with patients who live with chronic graft versus host disease and their caregivers. Families should not hesitate to seek this support for themselves as well as for the patient.[10]

Talking with other families who have been down the same path can be especially helpful. Speaking with other survivors and caregivers who understand the challenges makes people feel less alone. Support groups specifically for chronic graft versus host disease patients and caregivers provide a safe, private space to network with others who are living with the condition. These groups are often led by psychologists or social workers and offer practical strategies for coping.[10]

Peer support programs connect patients and families with others who have experienced stem cell transplantation and chronic graft versus host disease. These one-on-one connections allow people to share experiences, exchange practical advice, and find comfort in knowing they are not alone in their struggles. Family members can help their loved ones connect with these resources and may benefit from caregiver-specific support programs as well.[13]

The medical care of chronic graft versus host disease requires a profound team effort in which success depends on close cooperation between healthcare providers, patients, and caregivers. A multidisciplinary team approach that focuses on the individual’s needs and quality of life is strongly encouraged.[8] Family members are integral members of this team, providing practical assistance, emotional support, and advocacy to ensure patients receive comprehensive care.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Prednisone – A corticosteroid used as first-line treatment for chronic graft versus host disease, often combined with other immunosuppressive medications
  • Cyclosporine – An immunosuppressive drug commonly used in combination with prednisone to manage chronic graft versus host disease
  • Tacrolimus – An immunosuppressive medication used in combination with prednisone to control chronic graft versus host disease symptoms
  • Sirolimus – An immunosuppressive agent used in the treatment of chronic graft versus host disease
  • Ibrutinib (Imbruvica®) – A BTK inhibitor approved by the FDA for adults with chronic graft versus host disease after failure of one or more lines of therapy, representing the first FDA-approved drug specifically for this condition
  • Ruxolitinib – A JAK inhibitor approved for treatment of chronic graft versus host disease in adults and children 12 years of age and older who have taken corticosteroids and they did not work well enough
  • Belumosudil – A ROCK2 inhibitor approved for treatment of chronic graft versus host disease after other treatments have failed
  • Methotrexate – An immunosuppressive drug used when first-line treatments do not provide adequate response
  • Mycophenolate mofetil – An immunosuppressive medication used for managing chronic graft versus host disease when initial treatments are insufficient
  • Extracorporeal photopheresis – A treatment procedure where blood cells are treated outside the body and returned to manage chronic graft versus host disease

Ongoing Clinical Trials on Chronic graft versus host disease

  • Study of Axatilimab compared to standard therapy in children with chronic graft-versus-host disease who have previously received at least 2 treatments

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Germany Italy Spain
  • A Study of Belumosudil for Patients with Steroid-Resistant Overlap Syndrome Graft-versus-Host Disease

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study on Axatilimab and Corticosteroids for Initial Treatment of Chronic Graft-Versus-Host Disease in Patients

    Recruiting

    3 1 1
    Investigated diseases:
    Austria Denmark France Germany Ireland Italy +2
  • Study on Ruxolitinib and Methoxsalen for Patients with Steroid-Refractory Chronic Graft-versus-Host Disease

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany
  • Study Comparing Axatilimab to Best Available Therapy for Patients with Chronic Graft-Versus-Host Disease After Two or More Treatments

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia Finland France Germany +8
  • Study of Axatilimab for Patients with Chronic Graft Versus Host Disease After Two Prior Treatments

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Greece Italy Spain
  • Study on Axatilimab and Ruxolitinib for Patients with Newly Diagnosed Chronic Graft-Versus-Host Disease

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Belgium Germany Italy Spain
  • Study on Long-Term Safety of Ruxolitinib, Panobinostat, and Siremadlin for Patients Continuing Treatment from Previous Studies

    Not recruiting

    3 1 1 1
    Germany Italy Poland Sweden
  • Study on the Safety and Effectiveness of Ibrutinib for Children and Young Adults with Chronic Graft Versus Host Disease

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy The Netherlands Spain
  • Continued Treatment Study for Patients with Myelofibrosis, Post-Lung Transplant BOS, or Chronic Graft-Versus-Host Disease Using Itacitinib

    Not recruiting

    2 1 1
    Investigated drugs:
    Austria Belgium Germany Greece Italy Spain

References

https://my.clevelandclinic.org/health/diseases/10255-graft-vs-host-disease-an-overview-in-bone-marrow-transplant

https://www.ncbi.nlm.nih.gov/books/NBK538235/

https://bmtinfonet.org/transplant-article/chronic-graft-versus-host-disease

https://www.jakafi.com/chronic-graft-versus-host-disease/cgvhd/what-is-chronic-gvhd

https://www.nbmtlink.org/what-is-chronic-graft-versus-host-disease/

https://my.clevelandclinic.org/health/diseases/10255-graft-vs-host-disease-an-overview-in-bone-marrow-transplant

https://pmc.ncbi.nlm.nih.gov/articles/PMC3854558/

https://www.nature.com/articles/s41409-024-02370-8

https://www.dana-farber.org/for-physicians/clinical-resources/hematologic-malignancies/advances-newsletter/2024-issue-19/chronic-gvhd

https://bmtinfonet.org/transplant-article/coping-stress-gvhd

https://www.everydayhealth.com/gvhd/tips-to-cope/

https://www.nbmtlink.org/living-with-graft-versus-host-disease-how-i-stopped-fighting-cancer-and-started-healing/

https://www.gvhdalliance.org/resources/

https://www.cancerresearchuk.org/about-cancer/coping/physically/gvhd/coping-chronic

https://www.anthonynolan.org/patients-and-families/recovering-a-stem-cell-transplant/graft-versus-host-disease-gvhd

FAQ

What is the difference between acute and chronic graft versus host disease?

Acute graft versus host disease usually develops within the first 100 days after transplant and primarily affects the skin, gastrointestinal tract, and liver. Chronic graft versus host disease typically appears later (though it can occur at any time) and tends to develop more slowly, affecting many more organs including the skin, mouth, liver, lungs, gastrointestinal tract, muscles, joints, and genitals. The symptoms of chronic graft versus host disease often include tissue thickening and scarring, similar to autoimmune diseases.[1][4]

Who is most at risk for developing chronic graft versus host disease?

Chronic graft versus host disease occurs most often in patients who previously had acute graft versus host disease, are older, were transplanted with cells from an unrelated donor or a donor who was not a perfect match, received stem cells from the bloodstream rather than bone marrow or cord blood, are male and received cells from a female donor, or are male or female who received cells from a female donor who had previously borne children.[3]

How long will I need treatment for chronic graft versus host disease?

Patients with chronic graft versus host disease usually require treatment for three to five years. However, approximately 15 percent of patients require treatment for a longer period of time and, in rare cases, may need lifelong immunosuppressive drugs. The length of treatment depends on which organs are affected, the severity of symptoms, and how well you respond to therapy. It’s important to continue taking medication even when you start to feel better, as stopping too early can cause symptoms to flare up again or worsen.[3]

What should I do if I notice new symptoms after my transplant?

Because chronic graft versus host disease usually develops more than 100 days after transplant when weekly visits with the transplant team have ended, it’s important to examine your body weekly for signs of the disease. Carefully inspect your mouth, eyes, skin, joints, and genitals for any changes. Don’t ignore subtle changes or assume they’re nothing to worry about – report anything unusual to your doctor immediately. Early detection and treatment can prevent permanent damage to affected organs.[3]

Can chronic graft versus host disease be cured?

Active chronic graft versus host disease most often goes away within five to eight years, though this may not always happen without some permanent damage to affected organs. Many people see gradual improvement over several months, with the average duration ranging from one to three years. While the condition may resolve, some patients experience lasting effects. Treatment focuses on managing symptoms, preventing complications, and maintaining quality of life until the disease runs its course.[5][14]

🎯 Key takeaways

  • Chronic graft versus host disease is a paradox – it’s a complication of the very treatment that saves lives, where donor cells attack the body they were meant to heal
  • Weekly self-examination becomes your responsibility after day 100, since you’ll see your transplant team less frequently when chronic symptoms typically emerge
  • The disease can affect virtually any part of your body, from your eyes and mouth to your skin, lungs, liver, joints, and even your genitals
  • For the first time in history, several FDA-approved drugs specifically target chronic graft versus host disease, offering hope beyond traditional corticosteroids
  • Living with this condition is often described as a marathon, not a sprint – requiring years of treatment but with most cases resolving within five to eight years
  • The emotional toll can match the physical burden, with depression and anxiety being normal responses that deserve professional support, not shame
  • Clinical trials continue to offer cutting-edge treatment options, especially valuable when standard therapies fail to control symptoms
  • A multidisciplinary team approach – including specialists for different organs, mental health professionals, and family caregivers – provides the best chance for managing this complex condition successfully